Jenny J. Yang
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$7.9MFederal grants as PI12 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
12 awards · $7.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 11, 2026 | NIH | STTR Phase II Precision MRI with Protein Contrast Agent for Noninvasive Detection of Lung Fibrosis | $1.0M | INLIGHTA BIOSCIENCES, LLC |
| Aug 25, 2025 | NIH | STTR Phase II Precision MRI with Protein Contrast Agent for Noninvasive Detection of Lung Fibrosis | $1.0M | INLIGHTA BIOSCIENCES, LLC |
| Aug 30, 2024 | NIH | STTR Phase I Design of Calcium-sensing Receptor Targeted Thera(g)nostic Agents | $324K | INLIGHTA BIOSCIENCES, LLC |
| Sep 15, 2023 | NIH | STTR Phase I Precision MRI with a Novel Protein Contrast Agent for Early Detection and Staging of Lung Fibrosis | $299K | INLIGHTA BIOSCIENCES, LLC |
| Sep 22, 2022 | NIH | SBIR Phase II Non-invasive staging of Metastasis by Precision MRI | $954K | INLIGHTA BIOSCIENCES, LLC |
| Jun 26, 2020 | NIH | STTR Phase II Detection and Staging of Liver Fibrosis by Precise MRI (pMRI) | $667K | INLIGHTA BIOSCIENCES, LLC |
| Jul 3, 2019 | NIH | STTR Phase II Detection and Staging of Liver Fibrosis by Precise MRI (pMRI) | $667K | INLIGHTA BIOSCIENCES, LLC |
| Jun 20, 2019 | NIH | STTR Phase II Noninvasive Contrast Enhanced Early Detection of Melanoma Liver Metastasis | $669K | INLIGHTA BIOSCIENCES, LLC |
| Aug 29, 2018 | NIH | STTR Phase II Detection and Staging of Liver Fibrosis by Precise MRI (pMRI) | $667K | INLIGHTA BIOSCIENCES, LLC |
| May 31, 2018 | NIH | STTR Phase II Noninvasive Contrast Enhanced Early Detection of Melanoma Liver Metastasis | $729K | INLIGHTA BIOSCIENCES, LLC |
| May 24, 2017 | NIH | STTR Phase II Noninvasive Contrast Enhanced Early Detection of Melanoma Liver Metastasis | $602K | INLIGHTA BIOSCIENCES, LLC |
| Sep 24, 2016 | NIH | STTR Phase I Molecular Imaging of Early Stage of Liver Fibrosis by Novel Protein Agents | $239K | INLIGHTA BIOSCIENCES, LLC |
Peer ranks
Federal funding#119
Awards as PI#97
Patents#505
Companies
- INLIGHTA BIOSCIENCES, LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.